|
|
|
|
- September 10, 2008
Bioxel Pharma seeks to reprice warrants issued in November 2007
- August 29, 2008
2008 Second Quarter Results
- August 12, 2008
Bioxel Grants Options to its New President and Chief Executive Officer
- July 16, 2008
Appointment of Olivier Meyer as President and Chief Executive Officer of Bioxel Pharma
- July 15, 2008
Bioxel Announces Issuance of Shares in Payment of Interests on 2002 Debentures
- July 8, 2008
Bioxel Pharma Achieves Major Advances in June 2008
- May 29, 2008
First Quarter 2008 Results
- May 22, 2008
Bioxel Announces Issuance of Shares on Payment of Interests on 2007 Debentures
- May 15, 2008
Bioxel Pharma Obtains $1 M in Financing
- May 13, 2008
Bioxel: First International Agreements for Docetaxel
- April 29, 2008
Bioxel Pharma Inc. Announces Changes To Its Management Team
- April 9, 2008
Fiscal 2007 Results
- April 1, 2008
Two International Reports on Patentability Confirm the Strenght of Bioxel’s Docetaxel Patent Applications
- March 3, 2008
Bioxel Announces Grant of Deferred Stock Units
- January 17, 2008
Moratorium on Repayment of Interest and Capital Under Certain Loans; Extension of a Loan Guarantee; and Issuance of 1,030,165 Warrants in Consideration Thereof
|
|
|
